A great many active constituents of botanical drugs bind to human serum albumin (HSA) reversibly with a dynamic balance between the free-and boundforms in blood. The curative or side effect of a drug depends on its free-form level, which is always influenced by other drugs, combined dosed or multiconstituents of botanical drugs. This paper presented a rapid and convenient methodology to investigate the drug-drug interactions with HSA. The interaction of two steroidal saponins, dioscin and pseudo-protodioscin, from a botanical drug was studied for their equilibrium time and equilibrium amount by re-ligand fishing using HSA functionalized magnetic nanoparticles. A clear competitive situation was obtained by this method. The equilibrium was reached soon about 15 s at a ratio of 0.44： 1. Furthermore, the interaction of pseudo-protodioscin to total steroidal saponins from DAXXK was also studied. The operation procedures of this method were faster and more convenient compared with other methods reported.
Botanical drugs are often mixtures of many active ingredients that could bind to human serum albumin (HSA) reversibly with a dynamic balance of the free-and bound-form in blood. The drug distribution of the free-or bound-form will probably be affected by the competitive binding with HSA, which is directly related to the curative or side effect. Therefore, it is of great importance to study botanical drug-drug interactions.
There has been much research on interactions between drugs and HSA using classical methods such as equilibrium dialysis [1] , ultrafiltration [2] , X-ray crystallography [3] , and mass spectrometry [4] , as well as some spectroscopic methods [5] . However, these methods are only suitable for pure compound study, not being able to detect multiple ingredients in a complex matrix. As for herb-drug interaction, the present studies concentrate mainly on the change in the curative effect of the drug, as well as the activity of CPY450 [6] [7] [8] , while very few studies are involved in the interaction between each single component. Herein we demonstrate that re-ligand fishing could be applied to study the drug-drug interactions, which is based on ligand fishing experiments with HSA functionalized magnetic nanoparticles (HSA-MNPs) used in our previous research [9] [10] [11] [12] . Ligand fishing based on receptor theory had been proposed as a new method for drug-protein interaction using a protein immobilized on the surface of MNPs for the isolation of ligands from a mixture of compound extracts [13] . Correspondingly, religand fishing was defined as HSA-MNPs saturated binding with one drug in advance and then ligand fish other drugs in the second ligand fishing experiment.
"Di Ao Xin Xue Kang" capsule (DAXXK), manufactured from the total steroid saponins extract of Dioscorea nipponica and D. panthaica, is a popular botanical medicine in China for prevention and treatment of coronary heart disease by inhibiting platelet aggregation [14] . It is an interesting phenomenon that a single saponin either inhibits or induces platelet aggregation [15, 16] , while the total steroid saponins has an obvious platelet aggregation inhibition activity due to multicomponent effective ingredients synergy and/or antagonistic action [17, 18] . There has been some research on the interaction between certain proteins with saponins from D. nipponica [19] [20] [21] . However, the interactions with HSA by individual steroid saponins have never been reported. Thus, in the present work, the drug-drug interaction with HSA between the two main constituents of DAXXK, dioscin and pseudo-protodioscin (ppd), were studied by re-ligand fishing using pseudo-protodioscin pre-saturated HSA-MNPs (ppd-HSA-MNPs). Mass spectrometry (MS) using an electrospray ionization source (ESI) was chosen for detection.
Different drugs, even with few structural differences, have different binding capacity to HSA. As shown in Fig 1, dioscin is an isospirostanol type steroid saponin with F ring closed, and pseudoprotodioscin (ppd) is a furostanol type steroid saponin with F ring opened. It was reported that dioscin is the inhibitor of platelet aggregation while pseudo-protodioscin is not. Dioscin and pseudoprotodioscin are two main ingredients of DAXXK. Thus, it is of great interest to investigate the dioscin-pseudo-protodioscin interaction with HSA by re-ligand fishing experiment. Our previous study revealed that dioscin had a greater affinity to HSA than pseudo-protodioscin [12] . Thus, HSA-MNPs presaturated with pseudo-protodioscin (ppd-HSA-MNPs) was used to ligand fish dioscin in this study. An excessive amount of pseudo- protodioscin was used to ensure that all the HSA binding sites were saturated with pseudo-protodioscin. The de-binding wash of the ppd-HSA-MNPs was performed in 1 mL buffer containing 50% acetonitrile by vigorous shaking. The supernatant was carefully removed and saved for MS analysis. The existence of pseudoprotodioscin de-bound from ppd-HSA-MNPs was revealed by the peak at m/z 1029 [M-H] -, which could easily be assigned as pseudo-protodioscin; this was confirmed by MS 2 .
Dioscin and pseudo-protodioscin were competitively bound with HSA at the same site. The dynamic interaction process and equilibrium amount of these two constituents could be rapidly reached using the ppd-HSA-MNPs re-ligand fish dioscin. It was anticipated that the ratio of dioscin/pseudo-protodioscin would be increased as the re-ligand fishing time increased, until the equilibrium point arrived. The re-ligand fishing time in five experiments, 3 s, 5 s, 10 s, 15 s and 25 s, was set as the different interaction time points for these two drug constituents. Their debinding wash solutions were named as A2-1, A2-2, A2-3, A2-4 and A2-5, respectively. The peak at m/z 867 [M-H]in the mass spectrum could be easily assigned to dioscin, which was confirmed by MS 2 . The mass spectra of A2-1, A2-2, A2-3, A2-4 and A2-5 showed the peaks of dioscin and pseudo-protodioscin, the height ratios of which correspond to their competitive binding; the results are summarized in Table 1 . It was obvious that the height ratio of dioscin/pseudo-protodioscin was gradually increased with the religand fishing time.
To calculate the amount of dioscin and pseudo-protodioscin, an eleven-point calibration curve was obtained with standard solutions at concentration ratios ranging from 8∶1 to 1∶128. Peak heights were used for the calculation. Linear regression analysis of the results yielded the following equations for the ratio of dioscin/pseudo-protodioscin: Y = 8.4247 X + 0.0157, r 2 = 0.998, where Y was the peak height ratio of dioscin/pseudo-protodioscin, X was the concentration ratio of dioscin/pseudo-protodioscin, and r 2 was the correlation coefficient. The concentration ratio of dioscin/pseudo-protodioscin calculated by peak heights was determined in solutions A2-1, A2-2, A2-3, A2-4 and A2-5, as shown in Table 1 , which reflected the dynamic interaction process intuitively. The equilibrium was reached after about 15 s at a ratio of 0.44∶1.
Among the steroidal saponins exhibiting activity for the prevention and treatment of coronary heart disease in DAXXK, there are two categories, the furostanol type and the isospirostanol type. Dioscin is the most important isospirostanol type and pseudo-protodioscin the most important furostanol type; both are determined in the Chinese Pharmacopoeia assay [14] . In this current study, further studies of the total steroidal saponins from DAXXK were conducted by comparison of ligand fishing results (de-binding wash solution B1) using HSA-MNPs and re-ligand fishing using ppd-HSA-MNPs (de-binding wash solution B2). were bound to HSA significantly in the ligand fishing experiment. The ratio of dioscin/pseudo-protodioscin in the B1 solution was 0.54: 1, calculated by peak heights. By contrast, the ratio changed to 0.07: 1 in the re-ligand fishing experiment (B2 solution). This result indicated that the equilibrium was changed significantly in the presence of some outside source of pseudo-protodioscin and the drug-drug interaction of each constituent in DAXXK was serious. Further, it was reported that both dioscin and pseudo-protodioscin were degradation products of 26 [22] . The assay standard for DAXXK in the Chinese Pharmacopoeia is the content of pseudoprotodioscin and total saponins [14] . However, unlike modern therapeutic drugs that are single active pure compounds, DAXXK is an herbal medicine that contains many active ingredients, and the chemical compositions always vary depending on the variety, origin, harvesting time and processing technique. Hence, the strong binding ingredients such as dioscin should be integrated into the quality control standard. It is necessary to monitor the drug blood concentration in clinical use, especially with combined use with narrow therapeutic index drugs (for example warfarin, digoxin). Furthermore, this work can be important for the evaluation of the pharmaceutical effect of a herb medicine containing multicomponents.
In summary, a rapid and convenient methodology was presented to determine the balance ratio and balance time of dioscin/pseudoprotodioscin interaction with HSA by re-ligand fishing using human serum albumin-functionalized magnetic nanoparticles. The equilibrium was reached soon after 15 s at the amount ratio of 0.44： 1. Furthermore, the interaction of pseudo-protodioscin to total steroidal saponins from DAXXK was also studied. The procedures with the aid of mass spectrometry detection were very sensitive, quick and convenient. These results revealed that re-ligand fishing coupled with MS detection could be applied to investigate the botanical drug-drug interactions.
Experimental
Preparation of HSA-MNPs： HSA functionalized MNPs (HSA-MNPs) were prepared following the procedures reported previously [9] [10] [11] [12] . Briefly, magnetic nanoparticles were prepared by coprecipitation with a molar ratio of Fe 2+ : Fe 3+ = 1: 2 at pH 10. MNPs were first coated with SiO 2 using TEOS. Secondly, the particles were dispersed in APTMS solution to add -NH 2 to the SiO 2 ; the resultant particles were then dispensed in the GD solution to provide -CHO to the surface. Finally, the -CHO coated MNPs were incubated with HSA to obtain HSA functionalized MNPs. HSA-MNPs were suspended in NH 4 Ac solution and kept at 4°C before use.
Re-ligand fishing experiments

Saturated binding pseudo-protodioscin to HSA-MNPs (ppd-HSA-MNPs):
A 225 μg/mL solution of pseudo-protodioscin was prepared using ammonium acetate buffer solution (10 mM/L, pH 7.4). One mL pseudo-protodioscin solution and 100 μL HSA-MNPs were added to a 4 mL Eppendorf tube. The tube was vigorously shaken for 2 min using a vortex oscillator, and then put aside for magnetic separation for 1 min. The supernatant was removed. The HSA-MNPs were washed 3 times with 1 mL of buffer solution, each by vigorously shaking for 1 min, and then the supernatants Re-ligand fishing coupled with MS detection for drug-drug interactions Natural Product Communications Vol. 10 (12) 2015 2163
were removed after magnetic separation. Hence, the pseudoprotodioscin saturated binding HSA-MNPs (ppd-HSA-MNPs) were obtained.
Detection binding amount of pseudo-protodioscin in ppd-HSA-MNPs:
The de-binding wash of the ppd-HSA-MNPs was performed in 1 mL buffer containing 50% acetonitrile by vigorous shaking for 2 min. The supernatant was carefully removed and saved (A1) for mass spectrometric analysis.
Re-ligand fish dioscin using ppd-HSA-MNPs for different times:
A 0.55 μg/mL solution of dioscin was prepared using ammonium acetate buffer solution (10 mM/L, pH 7.4). One mL dioscin solution was added to a 4 mL Eppendorf tube containing 100 μL ppd-HSA-MNPs. The tube was vigorously shaken for 3 s (re-ligand fish time investigated) using a vortex oscillator, and then put aside for magnetic separation for 1 min. The supernatant was removed. The ppd-HSA-MNPs were washed 3 times with 1 mL of buffer solution each by vigorous shaking for 1 min, and then the supernatants were removed, after magnetic separation. Finally, the de-binding wash was performed in 1 mL buffer containing 50% acetonitrile by vigorous shaking for 2 min. The supernatant was carefully removed and saved (A2-1).
Another 4 experiments were undertaken using the parallel procedures above as well. Four de-binding solutions A2-2, A2-3, A2-4 and A2-5 were obtained for mass spectrometric analysis by prolonging the re-ligand fishing time from 3 s (A2-1) to 5 s (A2-2), 10 s (A2-3), 15 s (A2-4) and 25 s (A2-5), respectively.
Re-ligand fish total steroidal saponins using ppd-HSA-MNPs:
First, a comparative ligand fishing experiment was made using HSA-MNPs. One mL DAXXK solution and 100 μL HSA-MNPs were added to a 4 mL Eppendorf tube. After vigorous shaken, magnetic separation, and buffer wash, the 50% acetonitrile debinding wash solution (B1, ligand fishing) was obtained for comparison with B2 below.
Then, a 52 μg/mL solution of the DAXXK solution was prepared using ammonium acetate buffer solution (10 mM/L, pH 7.4). One mL dioscin solution was added to a 4 mL Eppendorf tube containing 100 μL ppd-HSA-MNPs. The 50% acetonitrile debinding wash solution (B2, re-ligand fishing) was obtained following the same procedure. All the experiments above were repeated 3 times.
